These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15478634)

  • 1. [Evaluation of drug therapy based on the results of imaging].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2004; 106(7):916-20. PubMed ID: 15478634
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging neurochemical endophenotypes: promises and pitfalls.
    Martinez D; Broft A; Laruelle M
    Pharmacogenomics; 2001 Aug; 2(3):223-37. PubMed ID: 11535111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the use of positron emission tomography for neuroreceptor imaging in rabbit eyes.
    Wang WF; Ishiwata K; Kiyosawa M; Kawamura K; Oda K; Matsuno K; Kobayashi T; Mochizuki M
    Ophthalmic Res; 2004; 36(5):255-63. PubMed ID: 15583431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of PET in clinical trials of psychotropic drugs].
    Suhara T; Morimoto T
    Seishin Shinkeigaku Zasshi; 2005; 107(7):704-11. PubMed ID: 16250122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stimulants related mental disorders].
    Iyo M; Sekine Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):507-12. PubMed ID: 14626172
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular imaging for pharmacodynamics of psychotropic drugs].
    Suhara T
    Seishin Shinkeigaku Zasshi; 2007; 109(9):869-75. PubMed ID: 18213899
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram.
    Williams SM; Bryan-Lluka LJ; Pow DV
    Brain Res; 2005 May; 1042(2):224-32. PubMed ID: 15854594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Delirium tremens].
    Sakata S; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 2003; (40):432-6. PubMed ID: 14626154
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
    Milak MS; Ogden RT; Vinocur DN; Van Heertum RL; Cooper TB; Mann JJ; Parsey RV
    Biol Psychiatry; 2005 Jan; 57(1):102-6. PubMed ID: 15607307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
    Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Okada H; Minabe Y; Nakamura K; Suzuki K; Iwata Y; Tsuchiya KJ; Sugihara G; Mori N
    J Clin Psychopharmacol; 2006 Oct; 26(5):531-3. PubMed ID: 16974201
    [No Abstract]   [Full Text] [Related]  

  • 13. Western blot analysis of human and rat serotonin transporter in platelets and brain using site-specific antibodies: evidence that transporter undergoes endoproteolytic cleavage.
    Dmitriev AD; Factor MI; Segal OL; Pavlova EV; Massino YS; Smirnova MB; Yakovleva DA; Dmitriev DA; Kizim EA; Kolyaskina GI; Brusov OS
    Clin Chim Acta; 2005 Jun; 356(1-2):76-94. PubMed ID: 15936305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies.
    Voll RJ; McConathy J; Waldrep MS; Crowe RJ; Goodman MM
    Appl Radiat Isot; 2005 Sep; 63(3):353-61. PubMed ID: 15985372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo evaluation of expressed protein function by PET].
    Matsumoto R; Suhara T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):137-41. PubMed ID: 16045196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wrestling with restless legs.
    Sloand JA
    Sleep Med; 2005 Jul; 6(4):295-6. PubMed ID: 15978512
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular imaging of transgene expression in brain tumors].
    Ichikawa T; Terada K; Tamiya T; Basilion JP; Chiocca EA; Date I
    No Shinkei Geka; 2004 Aug; 32(8):805-24. PubMed ID: 15478648
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic studies on substance dependence].
    Ujiie H; Inada T; Harano M; Komiyayama T; Yamada M; Sekine Y; Sora I; Iwata N; Iyo M; Ozaki N
    Seishin Shinkeigaku Zasshi; 2004; 106(12):1598-603. PubMed ID: 15770963
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular genetics of attention-deficit/hyperactivity disorder.
    Faraone SV; Perlis RH; Doyle AE; Smoller JW; Goralnick JJ; Holmgren MA; Sklar P
    Biol Psychiatry; 2005 Jun; 57(11):1313-23. PubMed ID: 15950004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.